Literature DB >> 2189587

Antibiotic susceptibility of Escherichia coli isolates from inpatients with urinary tract infections in hospitals in Addis Ababa and Stockholm.

S Ringertz1, B Bellete, I Karlsson, G Ohman, M Gedebou, G Kronvall.   

Abstract

A high level of antimicrobial resistance of bacteria has been detected at the Tikur Anbessa Hospital (TAH), Addis Ababa, for many years. In contrast, at the Karolinska Hospital (KH), Stockholm, the level of resistance is low. Reported are the results of an investigation of the correlation between antibiotic usage and the antimicrobial resistance rates of Escherichia coli isolates from patients with urinary tract infections in these hospitals. At TAH the strains of E. coli isolated were considerably more resistant to all seven antibiotics tested. The level of multiresistance was 63% at TAH and 7% at KH. There were no significant differences in the total amount of antibiotics used in the two hospitals, except for antituberculosis agents. The strain biotypes and antibiograms, together with the length of patients' hospitalization before a positive urine culture was obtained, suggest that the majority of the strains from TAH were of nosocomial origin.

Entities:  

Mesh:

Year:  1990        PMID: 2189587      PMCID: PMC2393012     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  7 in total

1.  Hospital-acquired infections among surgical patients in Tikur Anbessa Hospital, Addis Ababa, Ethiopia.

Authors:  E Habte-Gabr; M Gedebou; G Kronvall
Journal:  Am J Infect Control       Date:  1988-02       Impact factor: 2.918

Review 2.  Resistance of bacteria to antibacterial agents: report of Task Force 2.

Authors:  T F O'Brien
Journal:  Rev Infect Dis       Date:  1987 May-Jun

3.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

4.  Urinary tract infections: aetiologic patterns and resistance.

Authors:  M Gedebou
Journal:  Ethiop Med J       Date:  1983-01

5.  Abbreviated surveillance of nosocomial urinary tract infections: a new approach.

Authors:  E E Costel; S Mitchell; A B Kaiser
Journal:  Infect Control       Date:  1985-01

6.  The bacteriology of nosocomial infections at Tikur Anbessa Teaching Hospital, Addis Ababa.

Authors:  M Gedebou; G Kronvall; E Habte-Gabr; S Ringertz
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1987-12

7.  Hospital-acquired infections among obstetric and gynaecological patients at Tikur Anbessa Hospital, Addis Ababa.

Authors:  M Gedebou; E Habte-Gabr; G Kronvall; S Yoseph
Journal:  J Hosp Infect       Date:  1988-01       Impact factor: 3.926

  7 in total
  4 in total

1.  Spread of a newly found trimethoprim resistance gene, dhfrIX, among porcine isolates and human pathogens.

Authors:  C Jansson; A Franklin; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

2.  Changing Trends in Prevalence and Antibiotics Resistance of Uropathogens in Patients Attending the Gondar University Hospital, Northwest Ethiopia.

Authors:  Moges Tiruneh; Sisay Yifru; Mucheye Gizachew; Kassie Molla; Yeshambel Belyhun; Feleke Moges; Mengistu Endris
Journal:  Int J Bacteriol       Date:  2014-03-10

3.  Prevalence and antibiotic susceptibility of Uropathogens from cases of urinary tract infections (UTI) in Shashemene referral hospital, Ethiopia.

Authors:  Wubalem Desta Seifu; Alemayehu Desalegn Gebissa
Journal:  BMC Infect Dis       Date:  2018-01-10       Impact factor: 3.090

4.  High Gastrointestinal Colonization Rate with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Emergence of Carbapenemase-Producing K. pneumoniae in Ethiopia.

Authors:  Kassu Desta; Yimtubezinash Woldeamanuel; Aklilu Azazh; Halima Mohammod; Dawit Desalegn; Damte Shimelis; Dereje Gulilat; Biruk Lamisso; Eyasu Makonnen; Alemayehu Worku; Kerstin Mannerqvist; Johan Struwe; Olov Aspevall; Eleni Aklillu
Journal:  PLoS One       Date:  2016-08-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.